PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, May/June 2015

Issue link:

Contents of this Issue


Page 24 of 43

25 May/June 2015 Pharmaceutical & Medical Packaging News • together with the label, remains attached to the container. Any attempt to remove the rest of the cap would destroy the label, the company reports. Simply using vial caps with covers isn't enough to provide tamper evidence, adds Dul. "Caps and crimpers can be pur- chased by counterfeiters and applied to vials without any evidence," he says. Flexi-Cap labeling systems can be developed to suit different container types, forms, and sizes. In addition, the top of the cap could carry bar codes or NFC chips for electronic tracking, and the label could feature holographs, color- shifting inks, void efects, or the machine- readable LaserSecure technology. LEACHABLES & EXTRACTABLES Dul reports seeing a growing inter- est in moving away from glass vials and syringes for parenteral drugs, but linger- ing concerns over introducing the poten- tial for extractables and leachables. "A variety of factors—including cost-efec- tiveness, break resistance, and conve- nience—explain the rising prominence of plastics in pharmaceutical packaging con- tainers," says Dul. "However, when com- pared with glass, plastic containers bring an increased risk of package-to-product migration, meaning that molecules from solvents and other substances contained in inks, adhesives, and film materials could potentially migrate through the packaging over time." Dul says that this potential drawback is especially relevant in the case of soft plastics. Schreiner MediPharm offers low- migration label solutions for plastic con- tainers to address the potential downside of such plastics. The company qualified special adhesive systems, materials, and inks to develop the ideal label design for particular plastics. To help potential users evaluate its low-migration labels, Schrein- er MediPharm conducted a study with an independent test laboratory on the migration tendency of various label com- positions. "The report will help reduce some of the testing needed," Dul says. 0 EssEntra to offEr LabELing soLutions at PharmaPack north amErica The pharmaceutical market is facing a number of ongoing challenges, and Essentra believes its packaging business unit can offer a number of solutions. The global packaging company, which com- pleted its acquisition of Clondalkin Spe- cialist Packaging Division at the end of January, will be showcasing its capabili- ties at the upcoming Pharmapack North America June 9-10 in New York City. " A s p a t i e n t d e m o g r a p h i c s s h i f t towards an older population, prescription regimes are becoming more complex— this means that the industry must explore new ways to help maximize the effciency of drug information delivery to ensure patient safety," explains Malcolm Waugh, Group Commercial Director, Essentra plc. At the same time, the pharmaceutical sector and related packaging industries are facing many changes in the face of strict requirements for quality and change control, Waugh says. "The structural changes that have occurred within the industry all focus on lowering costs— from a shift to generics to the cost sav- ings expected from the consolidation of end-market players," Waugh says. "At the same time, the governments con- tinue to increase regulations associated with packaging, from tamper-evidence to track and trace to the addition of elec- tronic patient information leafets for use in private structures and hospitals where caregivers and will have access to real- time updates on drug information." Essentra is working to provide support through "increasing the formats and fea- tures available on our cartons and labels to providing innovative ways to maximize the amount of information available to patients," he says. It is also developing a "diverse range of solutions from just the basics to enhanced features to support the cost pro- fle requirements of generics to the more consumer-centric OTC packaging." For instance, Essentra's Plurium leaf- let that features a foldable booklet and offers the ability to present data, draw- ings, graphs, and text via increasing the printable surface area, Waugh says. "The easy-to-read booklet style format is still easy to fold and small in size." In addition, "ComboPack delivers a pre- combined carton with literature for appli- cations where high-speed literature-leafet insertion is not appropriate or desired." Essentra is reporting that "carton volumes are increasing in the USA as the market is beginning to transition to the use of blister packs to encourage proper patient dosing through packaging rather than by instruction on a pill bottle," Waugh says. At Pharmapack North America, Essen- tra will be highlighting both Plurium and ComboPack along with its serializa- tion capabilities. "Driven by regulatory requirements in certain markets—par- ticularly export markets—customers are increasingly requesting serialization for use in product tracking," Waugh says. Essentra's "global footprint" allows the company "to offer a range of solutions to customers on an international basis with consistent quality and service," he says. "We are also offering vendor-managed inventory to deliver supply chain effciencies as well." ComboPack combines a carton and literature.

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, May/June 2015